Lazard Asset Management
GRDN

Lazard Asset Management’s Guardian Pharmacy Services GRDN Stock Holding History

Lazard Asset Management’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.55M Sell
147,502
-20,229
-12% -$661K 0.01% 536
2025
Q4 		$5.05M Sell
167,731
-83,110
-33% -$2.35M 0.01% 553
2025
Q3 		$6.58M Sell
250,841
-45,818
-15% -$1.09M 0.01% 508
2025
Q2 		$6.32M Buy
296,659
+103,146
+53% +$2.33M 0.01% 670
2025
Q1 		$4.11M Buy
193,513
+2,716
+1% +$55.7K 0.01% 740
2024
Q4 		$3.87M Buy
190,797
+860
+0.5% +$17.8K 0.01% 701
2024
Q3 		$3.19M Buy
+189,937
New +$3.2M ﹤0.01% 750

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Lazard Asset Management's GRDN Position: Q1 2026 in Review

Lazard Asset Management reduced its Guardian Pharmacy Services (GRDN) stake by 12% in Q1 2026, selling an estimated $661K and leaving 147,502 shares worth $5.55M. The position accounts for 0.01% of the portfolio, ranked #536.

Lazard Asset Management first reported a position in GRDN in Q3 2024 and has held it in 7 quarters since. The position peaked at $6.58M in Q3 2025. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Lazard Asset Management held 147,502 shares of Guardian Pharmacy Services worth $5.55M as of Q1 2026.
  • Lazard Asset Management sold 20,229 Guardian Pharmacy Services shares in Q1 2026, an estimated $661K.
  • Guardian Pharmacy Services made up 0.01% of Lazard Asset Management's portfolio in Q1 2026, its #536 holding.
  • Lazard Asset Management first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 7 quarters since.
  • Lazard Asset Management's Guardian Pharmacy Services position peaked at $6.58M in Q3 2025.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.